Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Chemotherapy|December 12, 2002
Antiproliferative properties of toremifene on AIDS-related Kaposi's sarcoma cellsAngela Hong, Bryan R LeighCancer|March 6, 2002
Choosing an optimal radioimmunotherapy dose for clinical responseSally J DeNardo, Lawrence E Williams, Bryan R Leigh, et al.European Journal of Nuclear Medicine and Molecular Imaging|August 5, 2011
In vivo near-infrared fluorescence imaging of CD105 expression during tumor angiogenesisYunan Yang, Yin Zhang, Hao Hong, et al.Biotechnology Annual Review|October 27, 2004
Radioimmunotherapy of non-Hodgkin's lymphoma: clinical development of the Zevalin regimenCharles P Theuer, Bryan R Leigh, Pratik S Multani, et al.Cancer Biotherapy & Radiopharmaceuticals|June 14, 2003
Additional radiation absorbed dose estimates for Zevalin radioimmunotherapyGregory A Wiseman, Bryan R Leigh, William L Dunn, et al.Plos One|December 17, 2011
Positron emission tomography imaging of CD105 expression with a 64Cu-labeled monoclonal antibody: NOTA is superior to DOTAYin Zhang, Hao Hong, Jonathan W Engle, et al.European Journal of Nuclear Medicine and Molecular Imaging|March 5, 2011
Positron emission tomography imaging of CD105 expression during tumor angiogenesisHao Hong, Yunan Yang, Yin Zhang, et al.European Journal of Nuclear Medicine and Molecular Imaging|September 13, 2011
Positron emission tomography imaging of CD105 expression with 89Zr-Df-TRC105Hao Hong, Gregory W Severin, Yunan Yang, et al.Molecular Pharmaceutics|July 13, 2012
Multimodality imaging of breast cancer experimental lung metastasis with bioluminescence and a monoclonal antibody dual-labeled with 89Zr and IRDye 800CWHao Hong, Yin Zhang, Gregory W Severin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2006
Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712Angela M Davies, Kari Chansky, Derick H M Lau, et al.Pageof 2